Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 119 results for osteoarthritis

  1. Osteoarthritis: care and management (CG177)

    This guidance has been updated and replaced by NICE guideline NG226.

    Clinical guideline
    Last updated
    19 October 2022

  2. Osteoarthritis in over 16s: diagnosis and management (NG226)

    This guideline covers the diagnosis, assessment and non-surgical management of osteoarthritis. It aims to improve management of osteoarthritis and the quality of life for people with osteoarthritis.

    NICE guideline
    Published
    19 October 2022
    View recommendations

    Sections for NG226

  3. Osteoarthritis in over 16s (QS87)

    This quality standard covers diagnosing, assessing and managing osteoarthritis in adults aged over 16. It includes treatment and support, and referral for joint surgery. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    19 October 2022
    View quality statements

    Sections for QS87

  4. Focal resurfacing implants to treat articular cartilage damage in the knee (IPG734)

    Evidence-based recommendations on focal resurfacing implants to treat articular cartilage damage in the knee in adults. This involves replacing the damaged area with an artificial implant.

    Interventional procedures guidance
    Published
    24 August 2022
    View recommendations

    Sections for IPG734

  5. Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus) (IPG727)

    Evidence-based recommendations on synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus). This involves replacing damaged cartilage with an artificial (synthetic) implant.

    Interventional procedures guidance
    Published
    1 June 2022
    View recommendations

    Sections for IPG727

  6. Evidence on the safety and efficacy of supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis is limited in quality and quantity. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

    of supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis is limited in quality and quantity. Therefore, this...

    Research recommendation
    Published
    1 June 2022

  7. Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis (IPG726)

    Evidence-based recommendations on supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis in adults. This involves replacing a hip using smaller cuts than are used in standard surgery.

    Interventional procedures guidance
    Published
    25 May 2022
    View recommendations

    Sections for IPG726

  8. Romosozumab for treating severe osteoporosis (TA791)

    Evidence-based recommendations on romosozumab (EVENITY) for severe osteoporosis in people after menopause who are at high risk of fracture.

    Technology appraisal guidance
    Published
    25 May 2022
    View recommendations

    Sections for TA791

  9. Healthier lifestyle can help to ease osteoarthritis symptoms says NICE

    Exercise has an important role to play in helping people living with osteoarthritis NICE says in draft updated guidelines published today (29th April 2022) on the care and management of people with the condition.

    News
    Published
    29 April 2022

  10. Joint replacement (primary): hip, knee and shoulder (QS206)

    This quality standard covers care for adults before, during and after primary elective hip, knee or shoulder joint replacement. It describes high-quality care in priority areas for improvement. It does not cover joint replacement as treatment for primary or secondary cancer affecting the bones.

    Quality standard
    Published
    29 March 2022
    View quality statements

    Sections for QS206

  11. AposHealth for knee osteoarthritis (MIB284)

    This medtech innovation briefing has been updated and replaced by NICE medical technologies guidance 76. 

    Medtech innovation briefing
    Published
    1 February 2022

  12. Evidence on the safety of genicular artery embolisation for pain from knee osteoarthritis shows no major safety concerns in the short term. Evidence on its efficacy and long-term safety is inadequate in quality and quantity. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page. Research should preferably be randomised controlled trials against sham and current best practice. It should report details of patient selection and identify those who would most benefit from this procedure. It should also report details of the technique used, long-term safety, and patient-reported outcomes. The procedure should only be done by interventional radiologists with specific training in this technique.

    Evidence on the safety of genicular artery embolisation for pain from knee osteoarthritis shows no major safety concerns in the short...

    Research recommendation
    Published
    5 November 2021

  13. Genicular artery embolisation for pain from knee osteoarthritis (IPG708)

    Evidence-based recommendations on genicular artery embolisation for pain from knee osteoarthritis. This involves inserting a tube through an artery in the groin into the genicular artery, and injecting tiny particles through it to block new blood vessels.

    Interventional procedures guidance
    Published
    27 October 2021
    View recommendations

    Sections for IPG708

  14. Pregnancy and neonates: hip screening (IND77)

    This indicator covers the proportion of babies with a screen positive newborn hip result who attend for ultrasound scan of the hips within the designated timescale. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG96

    Network / system level indicators
    Published
    26 October 2021

  15. Evidence on the safety of magnetic resonance therapy for knee osteoarthritis shows no major safety concerns. Evidence on efficacy is inadequate in quality and quantity and shows no benefit over placebo. Therefore, this procedure should not be used unless it is part of a research study. Further research should be in the form of appropriately powered randomised  controlled trials comparing the procedure with placebo. It should report patient  selection and treatment protocols, including the number of sessions and  magnetic field strength.

    Question Evidence on the safety of magnetic resonance therapy for knee osteoarthritis shows no major safety concerns. Evidence on...

    Research recommendation
    Published
    30 September 2021